Trial reportMuscle & nerve2026
Effect of Capsaicin (8%) Topical System on Sensory Function in Patients With Diabetic Peripheral Neuropathy: Analysis of the PACE Study.
Trial report in Muscle & nerve, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
INTRODUCTION/
aimsHigh-concentration capsaicin topical system (HCCTS) is an established treatment for painful diabetic peripheral neuropathy (PDPN). The PACE primary analysis showed that HCCTS + standard of care (SOC) was not associated with deterioration in nerve function compared with SOC alone over 52 weeks. This post hoc analysis of PACE evaluated sensory function changes in the feet after repeated 30-min HCCTS treatments + SOC.
methodsSensory function was assessed using the Brief Sensory Pain Examination (BSPE) alongside the Norfolk Quality of Life-Diabetic Neuropathy (QOL-DN) questionnaire and its small- and large-fiber subscales. Analysis 1 descriptively assessed shifts in sensory test results over 12 months in patients receiving one to seven 30-min HCCTS treatments + SOC. Analysis 2 statistically compared mean sensory scores over 12 months with HCCTS + SOC versus SOC alone in patients with below-normal baseline sensory function.
resultsAnalysis 1 (n = 156) showed that repeated HCCTS treatments were associated with shifts from below-normal to normal sensory function at Month 12 in 21.1%, 26.4%, and 22.8% of heat, cold, and sharp tests, respectively. Analysis 2 (HCCTS n = 88; SOC n = 89) demonstrated significant improvements with HCCTS + SOC versus SOC alone in BSPE heat (p = 0.009), sharp (p = 0.048), vibration (p = 0.008), and Norfolk QOL-DN total (p < 0.001) and large-fiber subscale scores (p < 0.001). DISCUSSION: Repeated 30-min HCCTS treatments + SOC improved peripheral sensory function over 12 months in PDPN patients with baseline sensory deficits. If confirmed in dedicated trials, sensory improvements may reduce diabetic foot complications by restoring protective sensation, possibly via neuroregenerative effects of HCCTS reported elsewhere.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.